In the article titled "Are We Inhibited? Renal Insufficiency Should Not Preclude the Use of ACE Inhibitors for Patients With Myocardial Infarction and Depressed Left Ventricular Function," published in the September 25th issue of the ARCHIVES (2000;160:2645-2650) in the "Results" subsection of the "Abstract" on page 2645, lines 8 through 11 should have read as follows: "In stratified models, the receipt of an ACE inhibitor was associated with a 37% (16%-52%) lower mortality for patients who had poor renal function (serum creatinine level, >265 µmol/L [>3 mg/dL] and a 16% (8%-23%) lower mortality for patients who had better renal function." The journal regrets the error.